1-4 of 4
Shannon L. Smiley, MD
Close
Sort by
Journal Articles

Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration.

Chenthil Rathnasabapathy, MD, Kathleen West, Ph.D, Gerald Fetterly, Ph.D, Minocher Battiwalla, MD, Shannon L Smiley, MD, Theresa Hahn, PhD, Karen Brown, NP, Karen Arnold, NP, Margaret Syta, NP, Pamela Paplham, NP, Joann Liu, NP, Philip L. McCarthy, MD
Journal: Blood
Blood (2009) 114 (22): 2276.
https://doi.org/10.1182/blood.V114.22.2276.2276
Published: 2009
Journal Articles

The Effects of Rituximab Added to Front-Line or Salvage Chemotherapy in Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing High-Dose Chemotherapy (HDC) and Autologous Stem Cell Transplant (ASCT).

Umeer Ashraf, MD, Ritika Mahajan, MBBS, Theresa Hahn, PhD, Shannon L Smiley, MD, Philip L. McCarthy, MD, Zale P. Bernstein, MD, Asher Alban Chanan-Khan, MD, Minoo Battiwala, Myron S. Czuczman, MD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2008) 112 (11): 1138.
https://doi.org/10.1182/blood.V112.11.1138.1138
Published: 2008
Journal Articles

BuCy Provides Equivalent Outcomes to VCyTBI as Conditioning Prior to Auto-SCT in Patients with Relapsed/Refractory NHL and Is a Valuable Option in Older (≥60 years) Patients.

Shannon L Smiley, MD, Theresa Hahn, PhD, Wei Tan, MS, Gregory Wilding, PhD, Minoo Battiwalla, MD, Philip L. McCarthy, Jr., MD
Journal: Blood
Blood (2008) 112 (11): 2176.
https://doi.org/10.1182/blood.V112.11.2176.2176
Published: 2008
Journal Articles

Heparins Inhibit Tumor Angiogenesis by Sequestering Fibroblast Growth Factor (FGF) from Tumor Vascular Endothelial Cells.

Shannon L. Smiley, MD, Dale O. Henry, BA, Shang-Chiung Chen, MS, Michael K.K. Wong, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2662.
https://doi.org/10.1182/blood.V106.11.2662.2662
Published: 2005